An artificial bone marrow microenvironment (ABME) platform for enhancing and regulating in-vitro as well as in vivo formation of stem cells has been created by scientist at NCCS, Pune. This technology can be incorporated into high throughput and micro-fluidic devices for drug screening and in-vitro toxicology testing. Continue reading
|TRL A: Technology concept formulated|
|TRL B: Proof-of-concept demonstrated in lab scale
|TRL C: Prototype developed and tested; technology demonstrated at pilot scale (or a scale close to eventual use)|
|TRL D: Product or service offering tested in real/ field trials; Trial use by test customers; Clinical Trials completed|
|TRL E: Commercial production/ service offerings in place|
|TRL F: Proven technology with respect to established market|
Venture Center, a not-for-profit technology business incubator located in Pune, has signed a memorandum of understanding (MoU) with the National Centre for Cell Science (NCCS), Pune on 18th September 2015, for scanning and showcasing capabilities and technology developed by NCCS scientists for interested partners in Industry and Start-ups.
This engagement was brought about to assist NCCS in advancing its research and development activities towards commercialization objectives and promoting entrepreneurial activities. During the period of this engagement, Venture Center will be communicating with scientists at NCCS and showcasing their technology and capabilities for potential collaborators from the industry. This information will be periodically updated on the website: http://www.venturecenter.co.in/nccs/. Terms of MoU are available for review for NCCS scientists.